Comprehensive proteomic analysis of influenza virus polymerase complex reveals a novel association with mitochondrial proteins and RNA polymerase accessory factors

Journal of Virology

Volumn 85, Issue 17, 2011, Pages 8569-8581

  Bradel Tretheway, Birgit G ^a,d   Mattiacio, Jonelle L ^b   Krasnoselsky, Alexei ^a   Stevenson, Catherine ^b   Purdy, David ^a   Dewhurst, Stephen ^b   Katzel, Michael G ^a,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOACYL TRANSFER RNA; APOPTOSIS INDUCING FACTOR; DNA DIRECTED RNA POLYMERASE; EPIDERMAL GROWTH FACTOR RECEPTOR; KARYOPHERIN ALPHA; MITOCHONDRIAL PROTEIN; RNA DIRECTED RNA POLYMERASE; RNA POLYMERASE; RNA POLYMERASE II; SIALIDASE; TRANSACTIVATOR PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; HOST RANGE; HUMAN; HUMAN CELL; INFLUENZA VIRUS; INFLUENZA VIRUS A H5N1; LIFE CYCLE; LIQUID CHROMATOGRAPHY; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN FUNCTION; PROTEOMICS; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; VIRUS ISOLATION; VIRUS VIRULENCE; WESTERN BLOTTING;

CELL LINE; CHROMATOGRAPHY, LIQUID; DNA-DIRECTED RNA POLYMERASES; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; MITOCHONDRIAL PROTEINS; PROTEIN SUBUNITS; PROTEOME; TANDEM MASS SPECTROMETRY; VIRUS REPLICATION;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 80052274996     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00496-11     Document Type: Article

References (70)

1. Bick, M. J., et al. 2003. Expression of the zinc-finger antiviral protein inhibits alphavirus replication. J. Virol. 77:11555-11562.
2. Bradel-Tretheway, B. G., et al. 2008. The human H5N1 influenza A virus polymerase complex is active in vitro over a broad range of temperatures, in contrast to the WSN complex, and this property can be attributed to the PB2 subunit. J. Gen. Virol. 89:2923-2932.
3. Bradrick, S. S., and M. Gromeier. 2009. Identification of gemin5 as a novel 7-methylguanosine cap-binding protein. PLoS One 4:e7030.
4. Brass, A. L., et al. 2009. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139:1243-1254.
5. Bussey, K. A., T. L. Bousse, E. A. Desmet, B. Kim, and T. Takimoto. 2010. PB2 residue 271 plays a key role in enhanced polymerase activity of influenza A viruses in mammalian host cells. J. Virol. 84:4395-4406.
6. Carr, S. M., E. Carnero, A. Garcia-Sastre, G. G. Brownlee, and E. Fodor. 2006. Characterization of a mitochondrial-targeting signal in the PB2 protein of influenza viruses. Virology 344:492-508.
7. Chandra, V., A. Kar-Roy, S. Kumari, S. Mayor, and S. Jameel. 2008. The hepatitis E virus ORF3 protein modulates epidermal growth factor receptor trafficking, STAT3 translocation, and the acute-phase response. J. Virol. 82:7100-7110.
8. Chen, C. J., et al. 2010. Differential localization and function of PB1-F2 derived from different strains of influenza A virus. J. Virol. 84:10051-10062.
9. Chen, W., et al. 2001. A novel influenza A virus mitochondrial protein that induces cell death. Nat. Med. 7:1306-1312.
10. Deng, T., et al. 2006. Role of ran binding protein 5 in nuclear import and assembly of the influenza virus RNA polymerase complex. J. Virol. 80: 11911-11919.
11. Eierhoff, T., E. R. Hrincius, U. Rescher, S. Ludwig, and C. Ehrhardt. 2010. The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells. PLoS Pathog. 6:e1001099.
12. Engelhardt, O. G., M. Smith, and E. Fodor. 2005. Association of the influenza A virus RNA-dependent RNA polymerase with cellular RNA polymerase II. J. Virol. 79:5812-5818.
13. Falcon, A. M., P. Fortes, R.M. Marion, A. Beloso, and J. Ortin. 1999. Interaction of influenza virus NS1 protein and the human homologue of Staufen in vivo and in vitro. Nucleic Acids Res. 27:2241-2247.
14. Fislova, T., B. Thomas, K. M. Graef, and E. Fodor. 2010. Association of the influenza virus RNA polymerase subunit PB2 with the host chaperonin CCT. J. Virol. 84:8691-8699.
15. Fodor, E., et al. 2002. A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase inhibits endonucleolytic cleavage of capped RNAs. J. Virol. 76:8989-9001.
16. Fodor, E., L. J. Mingay, M. Crow, T. Deng, and G. G. Brownlee. 2003. A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase promotes the generation of defective interfering RNAs. J. Virol. 77:5017-5020.
17. Gabriel, G., A. Herwig, and H. D. Klenk. 2008. Interaction of polymerase subunit PB2 and NP with importin 1 is a determinant of host range of influenza A virus. PLoS Pathog. 4:e11.
18. Gabriel, G., et al. 2011. Differential use of importin-alpha isoforms governs cell tropism and host adaptation of influenza virus. Nat. Commun. 2:156.
19. Gao, G., X. Guo, and S. P. Goff. 2002. Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein. Science 297:1703-1706.
20. Gonzalez, S., and J. Ortin. 1999. Distinct regions of influenza virus PB1 polymerase subunit recognize vRNA and cRNA templates. EMBO J. 18: 3767-3775.
21. Graef, K. M., et al. 2010. The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon. J. Virol. 84:8433-8445.
22. Hao, L., et al. 2008. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 454:890-893.
23. Hara, K., et al. 2001. Influenza virus RNA polymerase PA subunit is a novel serine protease with Ser624 at the active site. Genes Cells 6:87-97.
24. Hayakawa, S., et al. 2011. ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses. Nat. Immunol. 12:37-44.
25. Honda, A., T. Okamoto, and A. Ishihama. 2007. Host factor Ebp1: selective inhibitor of influenza virus transcriptase. Genes Cells 12:133-142.
26. Huang, D. W., B. T. Sherman, and R. A. Lempicki. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.Nat. Protoc. 4:44-57.
27. Huarte, M., J. J. Sanz-Ezquerro, F. Roncal, J. Ortin, and A. Nieto. 2001. PA subunit from influenza virus polymerase complex interacts with a cellular protein with homology to a family of transcriptional activators. J. Virol. 75:8597-8604.
28. Hughes, N. C., E. Y. Wong, J. Fan, and N. Bajaj. 2007. Determination of carryover and contamination for mass spectrometry-based chromatographic assays. AAPS J. 9:E353-E360.
29. Iwai, A., et al. 2010. Influenza A virus polymerase inhibits type I interferon induction by binding to interferon beta promoter stimulator 1. J. Biol. Chem. 285:32064-32074.
30. Jansa, P., C. Burek, E. E. Sander, and I. Grummt. 2001. The transcript release factor PTRF augments ribosomal gene transcription by facilitating reinitiation of RNA polymerase I. Nucleic Acids Res. 29:423-429.
31. Karlas, A., et al. 2010. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463:818-822.
32. Karpova, A. Y., M. Trost, J. M. Murray, L. C. Cantley, and P. M. Howley. 2002. Interferon regulatory factor-3 is an in vivo target of DNA-PK. Proc. Natl. Acad. Sci. U. S. A. 99:2818-2823.
33. Kawaguchi, A., and K. Nagata. 2007. De novo replication of the influenza virus RNA genome is regulated by DNA replicative helicase, MCM. EMBO J. 26:4566-4575.
34. Keller, A., A. I. Nesvizhskii, E. Kolker, and R. Aebersold. 2002. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 74:5383-5392.
35. Konig, R., et al. 2010. Human host factors required for influenza virus replication. Nature 463:813-817.
36. Kumar, N., Y. Liang, and T. G. Parslow. 2011. Receptor tyrosine kinase inhibitors block multiple steps of influenza A virus replication. J. Virol.
37. Langhammer, S., R. Koban, C. Yue, and H. Ellerbrok. 2011. Inhibition of poxvirus spreading by the anti-tumor drug gefitinib (Iressa). Antiviral Res. 89:64-70.
38. Liang, Y., A. Kurakin, and B. Roizman. 2005. Herpes simplex virus 1 infected cell protein 0 forms a complex with CIN85 and Cbl and mediates the degradation of EGF receptor from cell surfaces. Proc. Natl. Acad. Sci. U. S. A. 102:5838-5843.
39. Liu, H., et al. 2010. The ESEV PDZ-binding motif of the avian influenza A virus NS1 protein protects infected cells from apoptosis by directly targeting Scribble. J. Virol. 84:11164-11174.
40. Mankouri, J., S. Griffin, and M. Harris. 2008. The hepatitis C virus nonstructural protein NS5A alters the trafficking profile of the epidermal growth factor receptor. Traffic 9:1497-1509.
41. Mayer, D., et al. 2007. Identification of cellular interaction partners of the influenza virus ribonucleoprotein complex and polymerase complex using proteomic-based approaches. J. Proteome Res. 6:672-682.
42. Melen, K., et al. 2007. Nuclear and nucleolar targeting of influenza A virus NS1 protein: striking differences between different virus subtypes. J. Virol. 81:5995-6006.
43. Momose, F., et al. 2001. Cellular splicing factor RAF-2p48/NPI-5/BAT1/UAP56 interacts with the influenza virus nucleoprotein and enhances viral RNA synthesis. J. Virol. 75:1899-1908.
44. Moncorge, O., M. Mura, and W. S. Barclay. 2010. Evidence for avian and human host cell factors that affect the activity of influenza virus polymerase. J. Virol. 84:9978-9986.
45. Naito, T., et al. 2007. An influenza virus replicon system in yeast identified Tat-SF1 as a stimulatory host factor for viral RNA synthesis. Proc. Natl. Acad. Sci. U. S. A. 104:18235-18240.
46. Naito, T., F. Momose, A. Kawaguchi, and K. Nagata. 2007. Involvement of Hsp90 in assembly and nuclear import of influenza virus RNA polymerase subunits. J. Virol. 81:1339-1349.
47. Nesvizhskii, A. I., A. Keller, E. Kolker, and R. Aebersold. 2003. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75:4646-4658.
48. O'Neill, R. E., and P. Palese. 1995. NPI-1, the human homolog of SRP-1, interacts with influenza virus nucleoprotein. Virology 206:116-125.
49. Perez-Gonzalez, A., A. Rodriguez, M. Huarte, I. J. Salanueva, and A. Nieto. 2006. hCLE/CGI-99, a human protein that interacts with the influenza virus polymerase, is a mRNA transcription modulator. J. Mol. Biol. 362:887-900.
50. Rostovtseva, T. K., W. Tan, and M. Colombini. 2005. On the role of VDAC in apoptosis: fact and fiction. J. Bioenerg. Biomembr. 37:129-142.
51. Sanz-Ezquerro, J. J., T. Zurcher, S. de la Luna, J. Ortin, and A. Nieto. 1996. The amino-terminal one-third of the influenza virus PA protein is responsible for the induction of proteolysis. J. Virol. 70:1905-1911.
52. Shapira, S. D., et al. 2009. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139:1255-1267.
53. Sheppard, H. M., and X. Liu. 2000. Transcription by RNA polymerase II in DNA-PK deficient SCID mouse cells. Biochim. Biophys. Acta 1493:41-47.
54. Song, J., et al. 2011. The PA protein directly contributes to the virulence of H5N1 avian influenza viruses in domestic ducks. J. Virol. 85:2180-2188.
55. Straight, S. W., P. M. Hinkle, R. J. Jewers, and D. J. McCance. 1993. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J. Virol. 67:4521-4532.
56. Sui, B., et al. 2009. The use of Random Homozygous Gene Perturbation to identify novel host-oriented targets for influenza. Virology 387:473-481.
57. Sun, Y., et al. 2011. High genetic compatibility and increased pathogenicity of reassortants derived from avian H9N2 and pandemic H1N1/2009 influenza viruses. Proc. Natl. Acad. Sci. U. S. A. 108:4164-4169.
58. Suprynowicz, F. A., et al. 2010. The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification. J. Virol. 84:10619-10629.
59. Tarendeau, F., et al. 2007. Structure and nuclear import function of the C-terminal domain of influenza virus polymerase PB2 subunit. Nat. Struct. Mol. Biol. 14:229-233.
60. Tsujimoto, Y., and S. Shimizu. 2002. The voltage-dependent anion channel: an essential player in apoptosis. Biochimie 84:187-193.
61. Turan, K., et al. 2004. Nuclear MxA proteins form a complex with influenza virus NP and inhibit the transcription of the engineered influenza virus genome. Nucleic Acids Res. 32:643-652.
62. Ueda, M., et al. 2010. Highly pathogenic H5N1 avian influenza virus induces extracellular Ca2_ influx, leading to apoptosis in avian cells. J. Virol. 84: 3068-3078.
63. Vreede, F. T., A. Y. Chan, J. Sharps, and E. Fodor. 2010. Mechanisms and functional implications of the degradation of host RNA polymerase II in influenza virus infected cells. Virology 396:125-134.
64. Vreede, F. T., and E. Fodor. 2010. The role of the influenza virus RNA polymerase in host shut-off. Virulence 1:436-439.
65. Wang, P., P. Palese, and R. E. O'Neill. 1997. The NPI-1/NPI-3 (karyopherin alpha) binding site on the influenza a virus nucleoprotein NP is a nonconventional nuclear localization signal. J. Virol. 71:1850-1856.
66. Wang, P., et al. 2009. Nuclear factor 90 negatively regulates influenza virus replication by interacting with viral nucleoprotein. J. Virol. 83:7850-7861.
67. Watanabe, T., S. Watanabe, and Y. Kawaoka. 2010. Cellular networks involved in the influenza virus life cycle. Cell Host Microbe 7:427-439.
68. Wu-Baer, F., W. S. Lane, and R. B. Gaynor. 1998. Role of the human homolog of the yeast transcription factor SPT5 in HIV-1 Tat-activation. J. Mol. Biol. 277:179-197.
69. Zamarin, D., A. Garcia-Sastre, X. Xiao, R. Wang, and P. Palese. 2005. Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog. 1:e4.
70. Zhou, Q., and P. A. Sharp. 1996. Tat-SF1: cofactor for stimulation of transcriptional elongation by HIV-1 Tat. Science 274:605-610.